Key words: cGMP; cyclosporin; -arginine; nitric oxide Background. Cyclosporin (CsA)-induced vascular dysfunction has been attributed to a diminished role of the nitric oxide (NO)/cGMP-mediated vasodilator mechanism. The present study was aimed at investigating whether -arginine, the substrate of NO synthe-Introduction sis, ameliorates CsA-induced vascular dysfunction. Methods. Male Sprague-Dawley rats were used Cyclosporin (CsA) has been known to cause a number throughout the study. The thoracic aorta was isolated of side-effects that primarily affect the blood vessels from normal rats and acutely treated with CsA [1,2]. CsA-induced vascular dysfunction has been (10−4 mol/l, 60 min) in vitro, or the aorta was taken attributed to an attenuated role for the nitric oxide from rats treated with CsA (25 mg/kg/day, i.m., 1 (NO)/cGMP-dependent vasodilator mechanism [3] [4] [5] . week). The vascular relaxation response to acetylchol-Furthermore, -arginine among others, has been found ine, and tissue levels of NO metabolites and cGMP to reverse CsA-induced vascular dysfunction [6 ] . were determined. The vascular expression of NO syn-However, the precise point of derangement due to CsA thase (NOS) isoforms was also determined by western among steps ranging from the availability of -arginine, blot analysis.
Materials and methods
tion. Following chronic CsA treatment in the whole animal, the vasorelaxation response to acetylcholine was decreased significantly along with tissue levels of Cyclosporin treatment NO metabolites; this was preserved by -arginine- tissue accumulation of NO metabolites. -Arginine and Use. In the first series of experiments, the thoracic aorta supplementation did not modify the altered expression was isolated from normal rats and acutely exposed in vitro of NOS proteins.
to CsA (Sandimmun, Sandoz; 10−4 mol/l, 60 min) either Conclusion. These results suggest that CsA causes an alone or in combination with -arginine (10−3 mol/l ). In the -arginine-sensitive vascular dysfunction which is asso-second set of experiments, two groups of rats were treated ciated with impaired generation of NO and cGMP.
Recording isometric tension
10 min). The total protein solution was centrifuged at 100 000× g for 1 h. The supernatant was used for blotting The thoracic aorta was isolated and cut into 5-mm rings.
of iNOS, and the pellet was resuspended for blotting of The rings were suspended in a tissue bath containing physioecNOS. logical salt solution (PSS ) at 37°C, while being continuously Western blotting was performed according to the method bubbled with 95% O 2 -5% CO 2 (pH 7.4). The baseline load of Mattson and Higgins [8] , with slight modification. Protein placed on the rings was 2.0 g, and the changes in isometric samples (100 mg) were size-separated electrophoretically tension were recorded using a force-displacement transducer using a discontinuous system consisting of a 6% polyacryl-(Grass FT03). The composition (in mmol/l ) of PSS used amide resolving gel and 5% polyacrylamide stacking gel, and was NaCl 112, KCl 5, NaHCO 3 25, KH 2 PO 4 1.0, MgSO 4 transferred to a nitrocellulose membrane at 20 V and 100 mA 1.2, CaCl 2 2.5 and glucose 11.5. The aortic rings were overnight. The membranes were incubated with a 152500 precontracted with EC80 phenylephrine (3.5×10−6 mol/l ), dilution of monoclonal mouse anti-NOS antibodies and the relaxation response to acetylcholine was calculated ( Transduction Laboratories; Lexington, KY, USA), and as a percentage of the phenylephrine-induced maximum a horseradish-peroxidase-labelled goat anti-mouse IgG contraction.
(151000). The bound secondary antibody was detected by enhanced chemiluminescence (Amersham). The relative pro-
Colourimetric assay of nitrite/nitrate
tein levels were determined by analysing the signals of autoradiograms using the transmitter scanning video In the acute experiment, NO production in the thoracic aorta densitometer. was stimulated with acetylcholine (10−5 mol/l ) for 10 min, after which the reaction was stopped by a quick freeze with liquid nitrogen. In the chronically CsA-treated rats, trunk Statistical analysis blood and thoracic aorta were taken to determine the plasma and vascular tissue levels of NO metabolites.
Results are expressed as means±SEM. The statistical signiThe nitrite/nitrate assay was performed with a colourim-ficance of differences between the groups was determined etric NO assay kit (Oxford; Oxford, MI, USA). For the using ANOVA or unpaired t-test. spectrophotometric assay of nitrites with Griess reagent, 80 ml MOPS (50 mmol/l )/ EDTA (1 mmol/l ) buffer and 5 ml tissue samples were added to the wells in duplicate. Nitrate Results reductase (0.01 U ) and 10 ml NADH (2 mmol/l ) were added to the reaction mixture, and the plate was shaken for 20 min Treatment with CsA in vitro significantly decreased the at room temperature. Colour reagents, sulfanilamide and Nvasorelaxation response to acetylcholine, which was (1-naphthyl ) ethylenediamine dihydrochloride were added, completely restored by -arginine ( Figure 1 ). The and the absorbance was read at 540 nm in a microtitre plate reader (Bio-Rad, Model 3550; Hercules, CA, USA). The acetylcholine-stimulated accumulation of NO metabolprotein concentration was determined using the method ites was decreased significantly by CsA, which was described by Bradford [7] with bovine serum albumin (BSA) prevented by cotreatment with -arginine ( Figure 2 ).
as standard. Figure 3 shows the amount of cGMP accumulated in responses to acetylcholine and sodium nitroprusside.
cGMP measurements
Acetylcholine-stimulated cGMP generation was decreased significantly by CsA-treatment, which was Aortic rings prepared from normal rats were incubated in restored, although not completely, by -arginine. 15 ml beakers at 37°C, while saturated with mixed gas of Sodium nitroprusside-stimulated cGMP formation was 95% O 2 -5% CO 2 (pH 7.4). An equilibration period of 1-2 h also decreased significantly by CsA, but was not, was allowed to elapse. The aortic rings were then treated however, significantly affected by -arginine.
with -arginine (10−3 mol/l ), CsA (10−4 mol/l ), or both for
Following chronic treatment with CsA in the whole 60 min, along with phenylephrine (3.5×10−6 mol/l ) and 3-isobutyl-1-methylxanthine (10−3 mol/l ), the phosphodiesterase inhibitor. They were then treated with acetylcholine (10−5 mol/l ) or sodium nitroprusside (3.5×10-7 mol/l ) for 10 min, which was terminated by a quick freeze with liquid nitrogen. The tissue homogenate made in 10% trichloroacetic acid was centrifuged at 2500 g for 30 min at 4°C. The supernatant was extracted four times with 3 ml of water-saturated ether, and the extract was acetylated and assayed for cGMP using a radioimmunoassay kit (Amersham; Buckinghamshire, UK ). The pellet was used for protein assay.
Protein preparation and western blot analysis
The aorta was homogenized with Polytron homogenizer at Fig. 1 . Effects of -arginine on the relaxation responses to acetylchol-3000 r.p.m. in a solution containing 250 mmol/l sucrose, ine in the aortic rings treated with and without CsA (10−4 mol/l, 1 mmol/l EDTA, 0.1 mmol/l phenylmethylsulfonyl fluoride 60 min). The rings were precontracted with phenylephrine. Numerals and 20 mmol/l potassium phosphate buffer, at pH 7.6. Large indicate the doses of acetylcholine (-log mol/l ). The arrow marks the point at which -arginine was added (10−3 mol/l ).
tissue debris and nuclear fragments were removed by two entative autoradiograms and densitometric data for vascular NOS proteins. Following CsA treatment, the animal, systolic blood pressure, measured by tail-cuff expression of ecNOS was not affected, whereas that methods without anaesthesia, did not differ significof iNOS was decreased significantly. -Arginine antly among the groups: 115±4 mmHg in CsA-treated, supplementation did not have a significant effect on 118±7 mmHg in the CsA-treated plus -arginine supthe altered NOS expression. plement and 110±4 mmHg in the control (n=5 each). The degree of acetylcholine-induced vasorelaxation was reduced by CsA treatment, which was prevented Discussion in part by -arginine supplementation (Figure 4) . The plasma concentrations of NO metabolites were not significantly altered by CsA-treatment (control: 100±15, The CsA-induced impairment of endotheliumdependent vasorelaxation has been attributed to a CsA: 103±23, CsA/-arginine: 112±16 mmol/l, n=6 each). In contrast, the vascular tissue content of reduced capacity to generate NO [9] [10] [11] . The present study also showed that either acute in vitro treatment NO metabolites was decreased significantly by CsA-treatment, which was restored by -arginine or chronic administration of CsA in the whole animal impaired the endothelium-dependent vasorelaxation, supplementation ( Figure 5 ). Figure 6 shows the repres-Vaziri et al. [11] 
novo synthesis of the NOS protein following a chronic administration of CsA. The ecNOS protein mass may not correlate with its enzymatic activity. The diminished NO formation may be related to an interference of calcium-dependent activation of ecNOS by CsA [15] .
CsA also significantly attenuated the stimulated formation of vascular cGMP, in response to sodium nitroprusside as well as to acetylcholine. It is likely that the step(s) beyond NO formation are also affected by CsA treatment. Guanylate cyclase activity per se may be inhibited by CsA, resulting in a failure to adequately stimulate cGMP formation in response to NO. Taken together, the mechanisms by which CsA impairs the vascular function should be multifactorial, including decreases in NOS and guanylate cyclase activities.
Interventions have been developed to reverse the CsA-induced vasculopathies. Among them has been the administration of -arginine, substrate to NOS, which is known to reverse vascular dysfunction due to CsA [6 ] . In the present study, we also observed that -arginine reversed the impairment of endotheliumdependent vasorelaxation. Furthermore, -arginine was able to preserve, at least in part, the vascular capacity to generate NO and cGMP. Therefore, the transport is mediated via a Na+-independent system y+ and a Na+-dependent system B0,+ in the pulmonary artery endothelial cells [16 ] . Further studies will be in association with reduced vascular tissue levels of necessary to determine whether this transport system NO metabolites. Although the plasma concentrations works in the same manner in the thoracic aorta. of NO metabolites were not significantly affected folIt may be of interest to point out that the attenuated lowing the chronic administration of CsA, the plasma vasorelaxation response to acetylcholine in the presence level may not necessarily reflect systemic NO producof CsA was completely restored by -arginine, despite tion [12] . It is likely that the reduced NO formation the incomplete recovery of cGMP response. This findin the vascular bed culminates in enhanced vasoconing suggests that the vasorelaxation event is not a striction and the development of hypertension. direct function of the tissue cGMP levels. Only a Along with the decrease in vascular content of NO certain level of cGMP may be sufficient to elicit a full metabolites, the vascular expression of iNOS was signirelaxation. In contrast, -arginine supplementation ficantly inhibited. This finding is in agreement with could not completely preserve the vasorelaxation previous reports, in which acutely administered CsA response to acetylcholine following the chronic CsA inhibited NOS induction in rat aortic smooth muscle treatment in the whole animal. This finding is in accord cells [10] or administration of CsA for 3 weeks resulted with a partial restoration of the CsA-induced impairin a marked reduction of vascular iNOS mRNA, as ment of acetylcholine-induced vasorelaxation by -well as protein expression [11] . It is suggested that arginine in different vascular species observed by previCsA exerts a transcriptional inhibition of iNOS in the ous investigators [17, 18] . The discrepancy in the effects vasculature.
of -arginine may be accounted for by the duration or In contrast, the expression of ecNOS was not signidosage of the treatment. It is also possible that other ficantly affected by the CsA treatment. This finding is factors, including increased production of superoxide contradictory to that reported by Lopez-Ongil et al.
radicals [19] , are also involved in the in vivo study.
[13] who observed enhanced NO synthesis in the In summary, the present study suggests that -presence of CsA along with the ecNOS transcript in arginine restores the impaired vascular capacity to cultured bovine aortic endothelial cells. However, recent in vivo studies do not support these findings. generate NO and cGMP.
